"Benzaldehydes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that consist of a benzene ring with a formyl group. They occur naturally in the seeds of many fruits and are used as FLAVORING AGENTS and fragrances, as well as precursors in pharmaceutical and plastics manufacturing.
| Descriptor ID |
D001547
|
| MeSH Number(s) |
D02.047.222
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Benzaldehydes".
Below are MeSH descriptors whose meaning is more specific than "Benzaldehydes".
This graph shows the total number of publications written about "Benzaldehydes" by people in this website by year, and whether "Benzaldehydes" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 1 | 2 |
| 2006 | 1 | 0 | 1 |
| 2008 | 1 | 2 | 3 |
| 2010 | 3 | 2 | 5 |
| 2011 | 1 | 1 | 2 |
| 2012 | 1 | 0 | 1 |
| 2013 | 0 | 2 | 2 |
| 2014 | 4 | 0 | 4 |
| 2015 | 0 | 1 | 1 |
| 2017 | 2 | 1 | 3 |
| 2019 | 1 | 0 | 1 |
| 2021 | 3 | 1 | 4 |
| 2022 | 1 | 2 | 3 |
| 2024 | 1 | 2 | 3 |
| 2025 | 0 | 1 | 1 |
Below are the most recent publications written about "Benzaldehydes" by people in Profiles.
-
Quantitative Control of Zn2+ Photorelease: A Step toward Decoding Mechanisms of Subsecond Metal Signaling in the Brain. Anal Chem. 2025 Sep 30; 97(38):20887-20896.
-
Effect of voxelotor on cerebral perfusion and cerebral oxygen metabolism and cardiac stress in adult patients with sickle cell disease. Am J Hematol. 2025 Jan; 100(1):78-84.
-
Lab-on-a-lollipop (LoL) platform for preventing food-induced toxicity: all-in-one system for saliva sampling and electrochemical detection of vanillin. Lab Chip. 2024 09 10; 24(18):4306-4320.
-
Oxygen tug-of-war, voxelotor, and the brain. Blood. 2024 05 23; 143(21):2113-2114.
-
Sickle Cell Disease: A Review. JAMA. 2022 07 05; 328(1):57-68.
-
Model-informed drug development of voxelotor in sickle cell disease: Population pharmacokinetics in whole blood and plasma. CPT Pharmacometrics Syst Pharmacol. 2022 06; 11(6):687-697.
-
Model-informed drug development of voxelotor in sickle cell disease: Exposure-response analysis to support dosing and confirm mechanism of action. CPT Pharmacometrics Syst Pharmacol. 2022 06; 11(6):698-710.
-
Increased hemoglobin affinity for oxygen with GBT1118 improves hypoxia tolerance in sickle cell mice. Am J Physiol Heart Circ Physiol. 2021 08 01; 321(2):H400-H411.
-
Time to rethink haemoglobin threshold guidelines in sickle cell disease. Br J Haematol. 2021 11; 195(4):518-522.
-
Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Haematol. 2021 May; 8(5):e323-e333.